Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2916 (LINC02916)

Target
LINC02916
Molecular classification
Long intergenic non-coding RNA, lincRNA
01

Overview

Long intergenic non-protein coding RNA 2916 (LINC02916) is a member of the lincRNA family—RNA genes transcribed from intergenic regions of the genome that do not code for proteins[1][5]. Generally exceeding 200 nucleotides in length, lincRNAs regulate gene expression at the transcriptional, post-transcriptional, and epigenetic levels[4]. Some lincRNAs modulate nearby (cis) or distant (trans) genes and serve as scaffolds for chromatin-modifying complexes, act as molecular sponges for microRNAs, or influence mRNA stability[2][3][4]. While many lincRNAs—including LINC02916—have poorly characterized or unknown biological roles, the class as a whole is increasingly implicated in cancer development and progression through the regulation of cell proliferation, apoptosis, and differentiation[2][3][4]. To date, LINC02916 itself is primarily a genomic locus annotation with scarce direct functional or disease-related data[1][5]. No evidence has established it as a therapeutic target or linked it to drug interactions, patient biomarkers, or specific mechanisms of action.

Other names
TCONS_00018175
02

Biological functions

Gene regulationEpigenetic regulationMicroRNA sponging
03

Disease associations

Cancer (general evidence for lincRNAs)Role may be context-dependent; specifics for LINC02916 not established

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2916 (LINC02916).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2916 (LINC02916).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call